{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444599599
| IUPAC_name = 2-(1,3,4-Oxadiazol-2-yl)phenol
| image = Fenadiazole.svg
| width = 160 px
| image2 = Fenadiazole 3D ball.png
| width2 = 180
| alt2 = Ball-and-stick model of the fenadiazole 3D ball.png molecule
<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 1008-65-7
| ATC_prefix = none
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1903897
| PubChem = 5380573
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 8YX6HIZ0IP
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 11595729

<!--Chemical data-->
| C=8 | H=6 | N=2 | O=2 
| molecular_weight = 162.14544 g/mol
| smiles            = C1=CC=C(C(=C1)C2=NN=CO2)O
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C8H6N2O2/c11-7-4-2-1-3-6(7)8-10-9-5-12-8/h1-5,11H
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = OINXXHYENYVYPB-UHFFFAOYSA-N
}}

'''Fenadiazole''' ('''Hypnazol''', '''Eudormil''', '''Viodor''') is a [[hypnotic]] drug<ref>GB Patent 902388 - Improvements in and relating to new derivatives of 1,3,4-oxadiazole and process for preparing same</ref> with a unique [[oxadiazole]]-based structure.<ref>Hans Brandenberger & Robert A. A. Maes. ''Analytical Toxicology for Clinical, Forensic and Pharmaceutical Chemists'', 1997</ref> It used to be manufactured by the French pharmaceutical company Laboratoires Jacques Logeais.<ref name=Merck>''The Merck Index'', 12th Edition.</ref>

==References==
{{Reflist|2}}


{{Hypnotics}}

[[Category:Hypnotics]]
[[Category:Oxadiazoles]]
[[Category:Phenols]]
[[Category:Sedatives]]


{{sedative-stub}}